Antisecretory factor as a potential health-promoting molecule in man and animals

Nutrition Research Reviews

Volumn 23, Issue 2, 2010, Pages 300-313

  Ulgheri, Caterina ^a   Paganini, Beatrice ^a   Rossi, Filippo ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Antisecretory factor; Diarrhoea; Inflammatory bowel disease; Specially processed cereals

Indexed keywords

ANTISECRETORY FACTOR; ANTISECRETORY FACTOR 16; B 221; BACTERIAL TOXIN; PEPTIDE DERIVATIVE; PLACEBO; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL FOOD; ANIMAL HUSBANDRY; ARTICLE; CEREAL; COGNITIVE DEFECT; DIARRHEA; DIET SUPPLEMENTATION; DRUG BINDING; EGG YOLK; ENTERITIS; FUNCTIONAL FOOD; GASTROENTERITIS; HEALTH PROMOTION; HEALTH STATUS; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HYPERBARISM; IMMUNE SYSTEM; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MASTITIS; MENIERE DISEASE; MORBIDITY; MORTALITY; NERVOUS SYSTEM; NONHUMAN; OUTCOME ASSESSMENT; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT BOWEL SYNDROME; VERTIGO;

ANIMALS; BRAIN; COGNITION DISORDERS; DIARRHEA; DIET; FUNCTIONAL FOOD; GASTROENTERITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; MENIERE DISEASE; NEUROPEPTIDES; PRESSURE;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; RATTUS; SUIDAE;

EID: 78650575217     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422410000193     Document Type: Article

References (111)

1. Lönnroth I, Lange S, Skadhauge E (1988) The antisecretory factors: inducible proteins which modulate secretion in the small intestine. Comp Biochem Physiol 90, 611-617.
2. Johansson E, Lönnroth I, Lange S, et al. (1995) Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion. J Biol Chem 270, 20615-20620.
3. Lange S, Jennische E, Johansson E, et al. (1999) The antisecretory factor: synthesis and intracellular localization in porcine tissues. Cell Tissue Res 296, 607-617. (Pubitemid 29253692)
4. Johansson E, Jennische E, Lange S, et al. (1997) Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 41, 642-645. (Pubitemid 27496143)
5. Lange S, Lönnroth I (2001) The antisecretory factor: synthesis, anatomical and cellular distribution, and biological action in experimental and clinical studies. Int Rev Cyt 210, 39-75. (Pubitemid 32888800)
6. Lange S (1982) A rat model for an in vivo assay of enterotoxic diarrhoea. FEMS Microbiol Lett 15, 239-242. (Pubitemid 13196377)
7. Rapallino MV, Cupello A, Lange S, et al. (2003) Antisecretory factor peptide derivatives specifically inhibit [3H]-g-amino-butyric acid/36Cl2 out ! in permeation across the isolated rabbit Deiters neuronal membrane. Acta Physiol Scand 179, 367-371.
8. Davidson TS, Hickey WF (2004) Distribution and immunoregulatory properties of antisecretory factor. Lab Invest 84, 307-319.
9. Björck S, Bosaeus I, Ek E, et al. (2000) Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept. Gut 46, 824-829. (Pubitemid 30329078)
10. United Nations (2008) United Nations Millennium Development Goals. http://www.un.org/millenniumgoals (accessed November 2009).
11. Bryce J, Boschi-Pinto C, Shibuya K, et al. (2005) WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365, 1147-1152.
12. Zaman S, Mannana J, Lange S, et al. (2007) B 221, a medical food containing antisecretory factor reduces child diarrhoea - a placebo controlled trial. Acta Paediatr 96, 1655-1659. (Pubitemid 47609778)
13. Laurenius A, Wängberg B, Lange S, et al. (2003) Antisecretory factor counteracts secretory diarrhoea of endocrine origin. Clin Nutr 22, 549-552. (Pubitemid 37455722)
14. Lallès JP, Bosi P, Janczyk P, et al. (2009) Impact of bioactive substances on the gastrointestinal tract and performance of weaned piglets: a review. Animal 3:1625-1643.
15. Berkeveld M, Langendijk P, Soede NM, et al. (2009) Improving adaptation to weaning: effect of intermittent suckling regimens on piglet feed intake, growth, and gut characteristics. J Anim Sci 87, 3156-3166.
16. Jennische E, Hanner P, Johansson E, et al. (2003) Antisecretory factor in the human cochlea and saccus endolymphaticus. Exp Clin Endocrinol Diabetes 111, 401-405.
17. Johansson E, Lange S, Lönnroth I (1997) Identification of an active site in the antisecretory factor protein. Biochim Biophys Acta 1362, 177-182. (Pubitemid 28164170)
18. Johansson E, Jonson I, Bosaeus M, et al. (2008) Identification of flotillin-1 as an interacting protein for antisecretory factor. Regul Pept 146, 303-309.
19. Vassileva EV, Ivanov AI, Nusrat A (2008) Flotillin-1 stabilizes caveolin-1 in intestinal epithelial cells. Biochem Biophys Res Commun 379, 460-465.
20. Langhorst MF, Reuter A, Stuermer CA (2005) Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci 62, 2228-2240. (Pubitemid 41500540)
21. Babuke T, Tikkanen R (2007) Dissecting the molecular function of reggie/flotillin proteins. Eur J Cell Biol 86, 525-532. (Pubitemid 47233374)
22. Allen JA, Halverson-Tamboli RA, Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8, 128-140.
23. Rossy J, Schlicht D, Engelhardt B, et al. (2009) Flotillins interact with PSGL-1 in neutrophils and, upon stimulation, rapidly organize into membrane domains subsequently accumulating in the uropod. PLoS ONE 4, e5403.
24. Katoh S, Kamimoto T, Yamakawa D, et al. (2009) Lipid rafts serve as signaling platform for Tie2 receptor tyrosine kinase in vascular endothelial cells. Exp Cell Res 315, 2818-2823.
25. Morgan MJ, Kim YS, Liu Z (2007) Lipid rafts and oxidative stress-induced cell death. Antioxid Redox Signal 9, 1471-1483. (Pubitemid 47255027)
26. Van der Goot FG, Harder T (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13, 89-97. (Pubitemid 32382330)
27. Li N, Mak A, Richards DP, et al. (2003) Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 3, 536-548. (Pubitemid 36428305)
28. Davidson TS, Hickey WF (2004) Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis. J Leukoc Biol 76, 835-844.
29. Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 239, 290-292. (Pubitemid 18061496)
30. Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4, 281-286. (Pubitemid 40873112)
31. Galofré M, Babot Z, García DA, et al. (2009) GABAA receptor and cell membrane potential as functional endpoints in cultured neurons to evaluate chemicals for human acute toxicity. Neurotoxicol Teratol 32, 52-61.
32. Madsen KK, Larsson OM, Schousboe A (2008) Regulation of excitation by GABA neurotransmission: focus on metabolism and transport. Results Probl Cell Differ 44, 201-221.
33. Medina I, Chudotvorova I (2006) GABA neurotransmission and neural cation-chloride co-transporters: actions beyond ion transport. Crit Rev Neurobiol 18, 105-112. (Pubitemid 350194063)
34. Leist M, Nicotera P (1998) Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res 239, 183-201. (Pubitemid 28366619)
35. Olney JW (2002) New insights and new issues in developmental neurotoxicology. Neurotoxicology 23, 659-668. (Pubitemid 36004732)
36. Lange S, Lönnroth I, Palm A, et al. (1985) An inhibitory protein of intestinal fluid secretion reverses neuronal GABA transport. Biochem Biophys Res Commun 130, 1032-1036. (Pubitemid 16250977)
37. Lange S, Lönnroth I, Palm A, et al. (1987) The effect of antisecretory factor on the permeability of nerve cell membrane to chloride ion. Pflügers Arch 410, 648-651. (Pubitemid 18011768)
38. Kim M, Wasling P, Xiao MY, et al. (2005) Antisecretory factor modulates GABAergic transmission in the rat hippocampus. Regul Pept 129, 109-118. (Pubitemid 40775793)
39. Gwynne RM, Bornstein JC (2007) Local inhibitory reflexes excited by mucosal application of nutrient amino acids in guinea pig jejunum. Am J Physiol Gastrointest Liver Physiol 292, G1660-G1670.
40. Krantis A (2000) GABA in the mammalian enteric nervous system. News Physiol Sci 15, 284-290. (Pubitemid 33205098)
41. Minocha A, Galligan JJ (1993) Excitatory and inhibitory responses mediated by GABAA and GABAB receptors in guinea pig distal colon. Eur J Pharmacol 230, 187-193. (Pubitemid 23025001)
42. Bayer S, Crenner F, Aunis D, et al. (2002) Effects of GABA on circular smooth muscle spontaneous activities of rat distal colon. Life Sci 71, 911-925. (Pubitemid 34655820)
43. Harrison AP, Bartels EM, Erlwanger KH, et al. (2004) Effects of antisecretory factor-derived peptides on contractions in guinea pig colon. Comp Biochem Physiol A 139, 143-148.
44. Göransson L (1997) Alternatives to antibiotics - the influence of new feeding strategies for pigs on biology and performance. In Recent Advances in Animal Nutrition, pp. 45-56 [PC Garnsworthy and J Wiseman, editors]. Nottingham, UK: Nothingham University Press.
45. Sigfridsson K, Lange S, Lönnroth I (1995) Anti secretory factor (ASF) and feed induced lectines (FIL) in sow and suckling piglet. In Book of Abstracts of the 46th Annual Meeting of the European Association for Animal Production (EAAP), p. 165, poster M 4.23 [JAM van Arendonk, editor]. Wageningen: Wageningen Press, Prague, September 1995.
46. Lange S, Martinsson K, Lönnroth I, et al. (1993) Plasma level of antisecretory factor (ASF) and its relation to postweaning diarrhoea in piglets. J Vet Med B 40, 13-18.
47. Lönnroth I, Lange S (1987) Intake of monosaccharides or aminoacids induces pituitary gland synthesis of proteins regulating intestinal fluid transport. Biochim Biophys Acta 925, 117-123. (Pubitemid 17153270)
48. Göransson L, Martinsson K, Lange S, et al. (1993) Feed-induced lectins in piglets. Feed-induced lectins and their effect on post weaning diarrhoea, daily weight gain and mortality. J Vet Med B 40, 478-484.
49. Lange S, Lönnroth I, Martinsson K (1994) Concentrations of antisecretory factor in eggs and in chicken blood plasma. Br Poult Sci 35, 615-620.
50. Eriksson A, Shafazand M, Jennische E, et al. (2003) Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial. Scand J Gastroenterol 38, 1045-1049. (Pubitemid 37352467)
51. Eriksson A, Shafazand M, Jennische E, et al. (2003) Antisecretory factor-induced regression of Crohns disease in a weak responder to conventional pharmacological treatment. Infl Bow Dis 9, 398-400. (Pubitemid 37461453)
52. Wapnir RA, Teichberg S (2002) Regulation mechanisms of intestinal secretion: implications in nutrient absorption. J Nutr Biochem 13, 190-199. (Pubitemid 34436901)
53. Lundgren O (2002) Enteric nerves and diarrhoea. Pharmacol Toxicol 90, 109-120. (Pubitemid 34289607)
54. Fordtran J (1967) Speculation on the pathogenesis of diarrhoea. Fed Proc 26, 1405-1414.
55. Petri WA Jr, Miller M, Binder HJ, et al. (2008) Enteric infections, diarrhoea, and their impact on function and development. J Clin Invest 118, 1277-1290. (Pubitemid 351500420)
56. Field M, Fromm D, al-Awqati Q, et al. (1972) Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 51, 796-804.
57. Fan E, ONeal CJ, Mitchell DD, et al. (2004) Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin. Int J Med Microbiol 294, 217-223. (Pubitemid 39381973)
58. Griffiths SL, Critchley DR (1991) Characterization of the binding sites for Escherichia coli heat-labile toxin type I in intestinal brush borders. Biochim Biophys Acta 1075, 154-161.
59. Mourad FH, ODonnell LJ, Dias JA, et al. (1995) Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut 37, 340-345.
60. Moss J, Vaughan M (1981) Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation. Mol Cell Biochem 37, 75-90.
61. Cooke HJ (1994) Neuroimmune signaling in regulation of intestinal ion transport. Am J Physiol 266, G167-G178. (Pubitemid 24094773)
62. Cassuto J, Fahrenkrug J, Jodal M, et al. (1981) Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut 22, 958-963. (Pubitemid 12193614)
63. Holmgren J, Svennerholm AM (1992) Bacterial enteric infections and vaccine development. Gastroenterol Clin North Am 21, 283-302.
64. Horstman AL, Kuehn MJ (2000) Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J Biol Chem 275, 12489-12496.
65. Kuehn MJ, Kesty NC (2004) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19, 2645-2655.
66. Holmner A, Askarieh G, Okvist M, et al. (2007) Blood group antigen recognition by Escherichia coli heat-labile enterotoxin. J Mol Biol 371, 754-764. (Pubitemid 47087821)
67. Lönnroth I, Lange S, Jennische E, et al. (2003) Cholera toxin protects against action by Clostridium difficile toxin A. The role of antisecretory factor in intestinal secretion and inflammation in rat. APMIS 111, 969-977. (Pubitemid 37352616)
68. Kelly CP, La Mont JT (1998) Clostridium difficile infection. Annu Rev Med 49, 375-390.
69. Lorrot M, Vasseur M (2007) How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol J 21, 4-31. (Pubitemid 46514955)
70. Kotloff KL, Winickoff JP, Ivanoff P, et al. (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77, 651-666.
71. Baldi F, Bianco MA, Nardone G, et al. (2009) Focus on diarrhoeal disease. World J Gastroenterol 15, 3341-3348.
72. Torres J, Jennische E, Lange S, et al. (1991) Clostridium difficile toxin A indues a specific antisecretory factor which protects against intestinal mucosal damage. Gut 32, 791-795.
73. Grøndahl ML, Sorensen H, Unmack MA, et al. (2002) Neuronal involvement in the effect of an antisecretory factor-derived peptide on induced secretion in the porcine small intestine. J Comp Physiol A 188, 589-594. (Pubitemid 36251508)
74. Goyal RK, Hirano I (1996) The enteric nervous system. N Engl J Med 334, 1106-1114. (Pubitemid 26120190)
75. Johansson E, Lönnroth I, Jonson I, et al. (2009) Development of monoclonal antibodies for detection of antisecretory factor activity in human plasma. J Immunol Methods 342, 64-70.
76. Jennische E, Johansson E, Hansson HA, et al. (2006) Immunohistochemical staining patterns using epitopespecific antibodies indicate conformation variants of antisecretory factor/S5a in the CNS. APMIS 114, 529-538. (Pubitemid 44252507)
77. Ferguson LR, Shelling AN, Browning BL, et al. (2007) Genes, diet and inflammatory bowel disease. Mutat Res 622, 70-83. (Pubitemid 47214578)
78. Fiasse R, Denis MA, Dewit O (2010) Chronic inflammatory bowel disease: Crohns disease and ulcerative colitis (article in French). J Pharm Belg 1, 1-9.
79. Levy RL, Olden KW, Naliboff BD (2006) Psychosocial aspects of the gastrointestinal disorders. Gastroenterology 130, 1447-1458.
80. Jess T, Riis L, Jespersgaard C, et al. (2005) Disease concordance, zygosity, and NOD2/CARD15 status: followup of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 100, 2486-2492. (Pubitemid 43919681)
81. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. (1998) Crohns disease in Olmsted County, Minnesota, 1940- 1993: incidence, prevalence, and survival. Gastroenterology 114, 1161-1168.
82. Ekesbo R, Nilsson PM, Sjölund K (2008) Effects of antisecretory factor (ASF) on irritable bowel disease. Scand J Primary Health Care 26, 106-110.
83. Tilg H (2008) Short bowel syndrome: searching for the proper diet. Eur J Gastroenterol Hepatol 20, 1061-1063.
84. Messing B, Crenn P, Beau P, et al. (1999) Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 117, 1043-1050. (Pubitemid 29512662)
85. Nightingale JM (2001) Management of patients with short bowel. World J Gastroenterol 7, 741-751.
86. Lange S, Bosaeus I, Jennische E, et al. (2003) Food-induced antisecretory factor activity is correlated to small bowel length in patients with intestinal resections. APMIS 111, 985-988. (Pubitemid 37352618)
87. Pagoldh M, Eriksson A, Heimtun E, et al. (2008) Effects of supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol 20, 1085-1093.
88. Dodi G, Spencer R (1996) Diarrhoea. In Outpatient Coloproctology, textbook and color atlas, pp. 486-489. Padova, Italy: Piccin Nuova Libraria.
89. OToole D, Ducreux M, Bommelaer G, et al. (2000) Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 88, 770-776. (Pubitemid 30091095)
90. Kaltsas GA, Besser GM, Grossman AB (2004) The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25, 458-511. (Pubitemid 38780668)
91. Flemming JB, Lee JE, Bouvet M, et al. (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230, 697-707. (Pubitemid 30191833)
92. Wängberg B, Westberg G, Thylen U, et al. (1996) Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 20, 892-899. (Pubitemid 26281920)
93. Brown KH (1990) Epidemiological relationship between malnutrition and chronic diarrhoea in infants and children. In Malnutrition in Chronic Diet-Associated Infantile Diarrhoea. Diagnosis and Management, pp. 209-234 [CH Lifschitz and B Nicols, editors]. San Diego, CA: Academic Press.
94. Mihrshahi S, Oddy WH, Peat JK, et al. (2008) Association between infant feeding patterns and diarrhoeal and respiratory illness: a cohort study in Chittagong, Bangladesh. Int Breastfeed J 3, 28.
95. Ziyane IS (1999) The relationship between infant feeding practices and diarrhoeal infections. J Adv Nurs 29, 721-726.
96. Saleemi MA, Zaman S, Akhtar HZ, et al. (2004) Feeding patterns, diarrhoeal illness and linear growth in 0-24- month-old children. J Trop Pediatr 50, 164-169. (Pubitemid 38807836)
97. Svensson K, Lange S, Lönnroth I, et al. (2004) Induction of antisecretory factor in human milk may prevent mastitis. Acta Pdiatr 93, 1228-1231. (Pubitemid 39099725)
98. Hanner P, Jennische E, Lange S, et al. (2004) Increased antisecretory factor reduces vertigo in patients with Menieres disease: a pilot study. Hear Res 190, 31-36. (Pubitemid 38402280)
99. Hanner P, Rask-Andersen H, Lange S, et al. (2010) Antisecretory factor-inducing therapy improves the clinical out come in patients with Ménières disease. Acta Otolaryngol 28, 223-227.
100. Vink R, Young A, Bennett CJ, et al. (2003) Neuropeptide release influences brain edema formation after diffuse traumatic brain injury. Acta Neurochir Suppl 86, 257-260.
101. Hoane MR, Kaplan SA, Ellis AL (2006) The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res 1125, 185-193. (Pubitemid 44848321)
102. Säljö A, Svensson B, Mayorga M, et al. (2009) Low levels of blast raises intracranial pressure and impairs cognitive function in rats. J Neurotrauma 27, 1345-1352.
103. Säljö A, Bolouri H, Mayorga M, et al. (2010) Low levels of blast raises intracranial pressure and impairs cognitive function in rats: prophylaxis with fermented cereal feed. J Neurotrauma 27, 383-389.
104. Jennische E, Bergström T, Johansson M, et al. (2008) The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res 1227, 189-197.
105. Armonda RA, Bell RS, Vo AH, et al. (2006) Wartime traumatic cerebral vasospasm: recent review of combat casualties. Neurosurgery 59, 1215-1225. (Pubitemid 44949729)
106. Jantzen JP (2007) Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol 21, 517-538.
107. Gallois M, Rothköttera HJ, Baileya M, et al. (2009) Natural alternatives to in-feed antibiotics in pig production: can immunomodulators play a role? Animal 3, 1644-1661.
108. Florkowski WJ, Elnagheeb AH, Huang CL (1998) Risk perception and new food production technologies. Appl Econ Lett 5, 69-73. (Pubitemid 128607712)
109. Jondreville C, Revy PS, Dourmad JY (2003) Dietary means to better control the environmental impact of copper and zinc by pigs from weaning to slaughter. Livest Prod Sci 84, 147-156. (Pubitemid 37496534)
110. Ulgheri C, Grilli E, Rossi F, et al. (2010) Effect of hydrothermally processed cereals on the performance of weaned piglets. Livest Sci (epublication ahead of print version).
111. Finkel Y, Bjarnason I, Lindblad A, et al. (2004) Specially processed cereals: a clinical innovation for children suffering from inflammatory bowel disease? Scand J Gastroenterol 39, 87-88. (Pubitemid 38221719)